Replies to post #580 on Protalix BioTherapeutics Inc (PLX)

[genisi]

The European Commission has granted marketing authorisation for Shire's VPRIV

http://www.checkorphan.org/grid/news/treatment/shire-announces-european-approval-of-vpriv-r-velaglucerase-alfa-for-the-treatment-of-type-1-gaucher-disease